# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marcus Aurelius (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC004-SYN-TD
- Date: 0174-06-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Octavia Ashworth-Nnamdi, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Five-week review, four weeks on omeprazole: reflux, biopsy result, sleep, and the remedy. **S**

## History of present illness

Mr. Aurelius returns four weeks after his endoscopy. The burning after meals eased within a week of starting omeprazole and has now gone, and he no longer wakes with a sour taste. He takes the capsule before breakfast each day, eats his main meal early in the evening and has raised the head of his bed. His appetite has come back and he has gained weight. He has had two CBT-I sessions, the first a fortnight ago, and keeps a sleep diary: he now goes to bed only when sleepy and gets up at a fixed hour. Ten days ago he decided, on his own, to take the herbal paste only on alternate nights. For the first three or four nights without it he felt restless and slept badly; that has settled, and he has no craving for it. He has not increased the amount on the nights he takes it. His stools are regular with polyethylene glycol two or three times a week. **S**

| Element | Detail |
|---|---|
| Reflux | Gone on omeprazole; no night waking from it |
| Sleep | Two CBT-I sessions; Insomnia Severity Index 12 |
| Remedy | Alternate nights for ten days, by his choice; brief restlessness that settled; no craving |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Appetite better; weight up; less tired |
| Gastrointestinal | Negative | No heartburn, pain after meals, difficulty swallowing, vomiting or black stools |
| Cardiovascular | Negative | No chest pain |
| Psychiatric | Positive | Sleep improving but still short; mood better; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 **S**
- Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitis **S**
- Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himself **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 64 kg; BMI 21.6 kg/m². All vital signs are synthetic.

PHQ-9: 5. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 5 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 64.0 kg; pulse 72, blood pressure 120/76 |
| Abdomen | Soft and non-tender |
| Neurological | No tremor, sweating, yawning or dilated pupils |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Reflux esophagitis, responding** (K21.00). Symptoms resolved on omeprazole with the meal changes. The gastric biopsy histology confirms no Helicobacter pylori and no gastritis, so no eradication is needed. **S**
   - Continue omeprazole 20 mg before breakfast to complete eight weeks, then stop and take it on demand for heartburn.
   - Keep the early evening meal and the raised bed head.
2. **Chronic insomnia, improving with CBT-I** (G47.00). Insomnia Severity Index 12, down from 17, after two sessions and with the reflux treated. **S**
   - Complete the six CBT-I sessions.
   - No hypnotic.
3. **Opium-containing remedy, now on alternate nights by his choice** (F11.90). A reduction he chose and made himself. The restlessness and poor sleep on the first nights without it were mild withdrawal, which settled; no other DSM-5-TR criterion is present, so the picture remains expected physiological dependence without opioid use disorder. No thoughts of self-harm. **S**
   - Stay at alternate nights for now; any further change is his decision, made slowly.
   - Never take a larger amount to make up for a missed night, since tolerance falls on the nights off.
   - Naloxone at the bedside; review at the next visit.
4. **Strain of command** (Z56.6). PHQ-9 5, down from 8. He now hands decisions to his deputy after the evening meal. **S**
   - Keep the protected evening hours.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Reflux symptoms: heartburn, chest pain after meals, regurgitation, night waking | Every visit | Completed today | Resolved within a week of omeprazole |
| Examination | Alarm features: difficulty or pain swallowing, bleeding, vomiting, weight loss, anemia | Every visit | Completed today | None; weight up to 64.0 kg |
| Laboratory | Helicobacter pylori histology | At endoscopy; result at the next visit | Completed today | Negative; no gastritis |
| Medication safety | Proton pump inhibitor: dose, timing before breakfast, and adherence | Eight weeks for erosive esophagitis, then the lowest effective dose or on demand | Completed today | Taken before breakfast daily; four more weeks, then on demand |
| Self-management | Meal timing, head-of-bed elevation, alcohol at night | Every visit | Completed today | Main meal early; head of bed raised; wine rarely at night |
| Medication safety | Opium-containing remedy: amount, pattern, benefits and harms, his own goals | Every visit | Completed today | Alternate nights for ten days, by his choice; same amount when taken |
| Medication safety | Reassessment after a change in opioid use | Within one to four weeks of a change | Completed today | Reviewed today, ten days after his change; benefits kept, brief withdrawal settled |
| Medication safety | Naloxone at home and no alcohol or sedatives with the remedy | Every visit | Completed today | At the bedside; no alcohol on remedy nights |
| Medication safety | DSM-5-TR opioid use disorder criteria | At intake and when the pattern changes | Completed today | Mild withdrawal on the first nights off, now settled; no other criterion |
| Survey | Suicide risk and safety review | Every visit | Completed today | No thoughts of self-harm |
| Survey | PHQ-9 and GAD-7 | At intake, at follow-up and at the end of the episode | Completed today | PHQ-9 5 |
| Survey | Insomnia Severity Index | At intake and at each review | Completed today | 12, down from 17 |
| Self-management | Cognitive behavioral therapy for insomnia (six sessions) with sleep diary | Weekly or every two weeks for six sessions | Completed today | Two sessions done; sleep diary kept |
| Self-management | Constipation on the opioid | Every visit | Completed today | Regular with polyethylene glycol two or three times a week |
| Laboratory | Cardiovascular risk and statin decision | Every four to six years by the PREVENT equations | Not indicated | Calcium score 0 with LDL 133 mg/dL and lipoprotein(a) 38 nmol/L: low risk; no statin; recalculate in four to six years |

## Goal progress

- A cardiac cause of the chest pain excluded within two weeks. Outcome by 0174-05-19: Normal ECG at intake; CT coronary angiography one week later: calcium score 0 and no plaque. **S**
- Chest and stomach pain after meals controlled, with appetite and weight returning. In progress; target 0174-08-25. **S**
- Insomnia Severity Index below 8 within four months. In progress; target 0174-08-25. **S**
- The remedy used as safely as he can: naloxone at home, never with alcohol or sleep medicines, and decisions about it his own. In progress; target 0174-08-25. **S**

## Guideline basis

- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (2022), American College of Gastroenterology (Am J Gastroenterol 2022;117(1):27-56)
- ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024), American College of Gastroenterology (Am J Gastroenterol 2024;119(9):1730-1753)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
- Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021), American Academy of Sleep Medicine (J Clin Sleep Med 2021;17(2):255-262)
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Ann Intern Med 2016;165(2):125-133)
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, hyperlipidemia and ischemic heart disease monographs (2026), Aether Forge

## Follow-up

- Preventive visit as booked; fifteen-week review after the omeprazole course. Return for heartburn that comes back most days, difficulty swallowing, or any chest pain on exertion. **S**
- Next scheduled visit 0174-07-28: periodic adult preventive visit. **S**
